Treatments & Interventions
Demeclocycline hydrochloride
substance
Tetracycline hydrochloride
substance
Minocycline hydrochloride
substance
Doxycycline calcium
substance
Doxycycline hyclate
substance
Doxycycline monohydrate
substance
Furazolidone
substance
Tetracycline phosphate complex
substance
Doxycycline
substance
Minocycline
substance
Demeclocycline
substance
Tetracycline
substance
Doxycycline hydrochloride
substance
Doxycycline anhydrous
substance
Clinical Trials
Recent Trials
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity
Evaluation of a Boosting Regimen With Oral Cholera Vaccine
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Quick Facts
- SNOMED CT
- 63650001
- UMLS CUI
- C0008354
- Fully Specified Name
- Cholera (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 30
- Known Treatments
- 14
- Clinical Trials
- 7
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.